ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Alnylam Pharmaceuticals Inc

Alnylam Pharmaceuticals Inc (ALNY)

242.93
-0.60
(-0.25%)
At close: March 04 4:00PM
242.93
-0.12
( -0.05% )
After Hours: 5:15PM

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 3.39B3.4B3.84B3.83B3.82B4.01B4.21B4.24B
Total Current Assets 2.54B2.52B2.99B2.98B2.99B3.17B3.36B3.3B
Cash and Equivalents 672.25M657.8M1.03B812.69M681.88M968.49M1.1B966.43M
Total Non-Current Assets 850.92M878.35M853.62M1.37B835.78M836.78M849.62M1.45B
Total Liabilities 3.65B3.81B4B4.05B4.04B4.01B4.17B4.17B
Total Current Liabilities 673.39M788.64M949.79M967.79M941.71M1.06B1.22B1.19B
Total Non-Current Liabilities 4B4.04B4.07B4.1B4.12B3.98B3.98B4.01B
Common Equity 1.24M1.25M1.26M1.26M1.27M1.28M1.29M1.29M
Retained Earnings -6.74B-7.02B-6.87B-7.01B-7.08B-7.09B-7.2B-7.29B
Year End December 30 2024 20172018201920202021202220232024
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 1.99B1.57B2.4B3.41B3.64B3.55B3.83B4.24B
Total Current Assets 1.76B1.2B1.72B2.61B2.81B2.69B2.98B3.3B
Cash and Equivalents 645.36M420.15M547.18M496.58M819.98M866.39M812.69M966.43M
Total Non-Current Assets 1.77B1.3B1.44B1.02B588.2M-158.22M-220.64M67.09M
Total Liabilities 228.3M272.84M956.44M2.39B3.06B3.7B4.05B4.17B
Total Current Liabilities 144.25M179.49M352.59M585.27M695.71M767.92M967.79M1.19B
Total Non-Current Liabilities 114.05M123.34M603.85M2B3.04B3.95B4.1B4.01B
Total Equity 1.77B1.3B1.44B1.02B588.2M-158.22M-220.64M67.09M
Common Equity 997k1.01M1.12M1.16M1.2M1.24M1.26M1.29M
Retained Earnings -2.15B-2.84B-3.73B-4.59B-5.44B-6.57B-7.01B-7.29B